Literature DB >> 21700937

Limited ability to activate protein C confers left atrial endocardium a thrombogenic phenotype: a role in cardioembolic stroke?

Jorge Cerveró1, Ramón Montes, Francisco España, Charles T Esmon, José Hermida.   

Abstract

BACKGROUND AND
PURPOSE: Atrial fibrillation is the most important risk factor for cardioembolic stroke. Thrombi form in the left atrial appendage rather than in the right. The causes of this different thrombogenicity are not well-understood. The goal herein was to compare the activation of the anticoagulant protein C and the thrombomodulin and endothelial protein C receptor/activated protein C receptor expression on the endocardium between right and left atria.
METHODS: We harvested the atria of 6 monkeys (Macaca fascicularis) and quantified their ability to activate protein C ex vivo and we measured the thrombomodulin and endothelial protein C receptor expression by immunofluorescence.
RESULTS: We found the ability to activate protein C decreased by half (P=0.028) and there was lower expression of thrombomodulin in the left atrial endocardium than the right (52.5±19.9 and 72.1±18.8 arbitrary intensity units, mean±standard deviation; P=0.028). No differences were detected in endothelial protein C receptor expression.
CONCLUSIONS: Impaired protein C activation on the left atrial endocardium attributable to low thrombomodulin expression may explain its higher thrombogenicity and play a role in cardioembolic stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21700937      PMCID: PMC3178262          DOI: 10.1161/STROKEAHA.111.614420

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

Review 1.  The cytoprotective protein C pathway.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

Review 2.  Phenotypic heterogeneity of the endothelium: II. Representative vascular beds.

Authors:  William C Aird
Journal:  Circ Res       Date:  2007-02-02       Impact factor: 17.367

Review 3.  Is atrial fibrillation an inflammatory disorder?

Authors:  Christopher J Boos; Richard A Anderson; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2005-11-08       Impact factor: 29.983

4.  Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain.

Authors:  H Ishii; H H Salem; C E Bell; E A Laposata; P W Majerus
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

5.  Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors.

Authors:  M de Divitiis; H Omran; R Rabahieh; B Rang; S Illien; R Schimpf; D MacCarter; W Jung; H Becher; B Lüderitz
Journal:  Am J Cardiol       Date:  1999-11-01       Impact factor: 2.778

6.  Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway.

Authors:  Z Laszik; A Mitro; F B Taylor; G Ferrell; C T Esmon
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

7.  Low level of circulating activated protein C is a risk factor for venous thromboembolism.

Authors:  F España; A Vayá; Y Mira; P Medina; A Estellés; P Villa; C Falcó; J Aznar
Journal:  Thromb Haemost       Date:  2001-12       Impact factor: 5.249

8.  Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; T Ohira; K Yamagishi; M Cushman
Journal:  J Thromb Haemost       Date:  2009-08-19       Impact factor: 5.824

9.  Valves of the deep venous system: an overlooked risk factor.

Authors:  Erin G Brooks; Winifred Trotman; Marilyn P Wadsworth; Douglas J Taatjes; Mark F Evans; Frank P Ittleman; Peter W Callas; Charles T Esmon; Edwin G Bovill
Journal:  Blood       Date:  2009-05-12       Impact factor: 22.113

10.  Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death.

Authors:  Verónica Hurtado; Ramón Montes; Jean-Christophe Gris; María L Bertolaccini; Alvaro Alonso; Miguel A Martínez-González; Munther A Khamashta; Kenji Fukudome; David A Lane; José Hermida
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113

View more
  4 in total

Review 1.  Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients.

Authors:  Alicja Bukowska; Matthias Hammwöhner; Domenico Corradi; Wisno Mahardhika; Andreas Goette
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-12-12

Review 2.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

3.  Endocardial Endothelial Dysfunction Progressively Disrupts Initially Anti then Pro-Thrombotic Pathways in Heart Failure Mice.

Authors:  Amanda Schoner; Christina Tyrrell; Melinda Wu; Jill M Gelow; Alicia A Hayes; Jonathan R Lindner; Kent L Thornburg; Wohaib Hasan
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

4.  Proteomics Analysis Reveals Diverse Molecular Characteristics between Endocardial and Aortic-Valvular Endothelium.

Authors:  A Aneesh Kumar; G S Ajith Kumar; Gopika Satheesh; Arun Surendran; Mahesh Chandran; Chandrasekharan C Kartha; Abdul Jaleel
Journal:  Genes (Basel)       Date:  2021-06-30       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.